Autres langues Gemina Laboratories Ltd.

Actions

GLAB

CA3686501071

Marché Fermé - Canadian Securities Exchange Autres places de cotation 19:49:10 04/07/2024			Varia. 5j.	Varia. 1 janv.
0,45 ^CAD	+12,50%		0,00%	-16,67%

31/05	Gemina Laboratories Ltd. annonce ses résultats pour l'exercice clos le 31 janvier 2024	CI
02/04	Les Laboratoires Gemina signent un premier accord de licence stratégique	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Gemina Laboratories : Commences Trading on	20/06
Gemina Labs to Present at the Life Science Investor Forum June 20th	17/06
Gemina Laboratories Ltd. Reports Earnings Results for the Full Year Ended January 31, 2024	31/05
Gemina Laboratories : Financial Statement Request Form	11/04
Gemina Laboratories : Notice of Meeting and Management Information Circular	11/04
Gemina Laboratories Sign First Strategic License Agreement	02/04
Gemina Laboratories Ltd. announced that it has received CAD 0.91 million in funding	18/03
Gemina Laboratories Ltd. announced that it expects to receive CAD 1 million in funding	22/02
Gemina Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	29/12
Gemina Laboratories Ltd. Announces the Resignation of Rob Porter as Director and President	29/12
READYGO DIAGNOSTICS INITIATES AN ASSAY DEVELOPMENT CONTRACT WITH GEMINA LABORATORIES FOR THE DETECTION OF DENGUE FROM SALIVA SAMPLES	10/10/23
Gemina Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	29/09/23
Gemina Laboratories : to participate in poster session at AACC scientific meeting	15/06/23
READYGO DIAGNOSTICS AND GEMINA LABORATORIES ANNOUNCE THE FEASIBILITY OF MYCOBACTERIUM TUBERCULOSIS (MTB) DIAGNOSIS IN SALIVA	05/06/23
Gemina Laboratories Ltd. Laboratories and ReadyGo Diagnostics Limited Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva	05/06/23
Gemina Laboratories Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023	01/06/23
Gemina Laboratories Ltd. Auditor Raises 'Going Concern' Doubt	31/05/23
Gemina Laboratories Ltd. Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement	17/05/23
READYGO DIAGNOSTICS AND GEMINA LABORATORIES ENTER AN ASSAY DEVELOPMENT AGREEMENT FOR THE RAPID DETECTION OF MYCOBACTERIUM TUBERCULOSIS (MTB)	19/04/23
Gemina Laboratories Ltd. announced that it has received CAD 2.604746 million in funding	27/03/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Gemina Laboratories Ltd.

Actions

GLAB

CA3686501071

Autres langues

Filtres